Background -Staphylococcus pseudintermedius is the principal pathogen causing bacterial skin infections in dogs. Photodynamic therapy (PDT) involving the combination of light and a topical photosensitizer is used to treat human skin infections. Although the antimicrobial effects of PDT have been demonstrated using in vivo and in vitro studies in humans, its effects on dogs and their pathogens are unclear.
Introduction
Staphylococcus pseudintermedius is the principal pathogen most commonly associated with cutaneous infections in dogs. 1, 2 Generally, skin infections caused by S. pseudintermedius can be treated topically, systemically, or using a combination of these approaches. Systemic antimicrobials are commonly used, 3 but various strains of S. pseudintermedius differ in their antimicrobial susceptibilities. 4, 5 In addition, the proportion of staphylococci which expresses multi-drug resistance has gradually increased worldwide. [5] [6] [7] [8] Thus, cutaneous cytological evaluation, culture and bacterial susceptibility tests are required to choose effective treatments. 9 Alternative methods to treat skin infections include phototherapy employing visible light. 10 Penetration of light in most biological tissues increases as the wavelength of light increases, particularly in the 400-700 nm range. Depending on the tissue type, penetration depth is less than 1 mm at 400 nm, 0.5-2 mm at 514 nm, 1-6 mm at 630 nm and maximal at 700 nm. 11 Thus, blue light (400-470 nm) is useful for treating skin conditions involving the epidermis. Furthermore, several in vitro and in vivo studies have demonstrated antimicrobial effects of blue light against several pathogens.
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The preferred light source for phototherapy has changed from lasers to light-emitting diodes (LEDs) because LEDs have broader wavelengths and are nonthermal light sources. Moreover, they are considered to be safe and are associated with a lower risk for causing eye damage compared to laser therapy. 11, 18 In people, phototherapy using blue LED light has been applied in the management of various skin conditions and has been proposed as a therapeutic alternative because of its remarkable bactericidal effects against skin pathogens. 15, [19] [20] [21] The use of a photosensitizer during phototherapy is desirable as these agents can enhance photodynamic reactions. The most widely used photosensitizing agent is d-aminolevulinic acid (ALA), a precursor of the endogenous photosensitizer protoporphyrin IX (PpIX). 22 Many bacteria produce ALA naturally and this metabolite is converted intracellularly into porphyrins. These porphyrins absorb mainly blue light and stimulate the production of singlet oxygen, which leads to destruction of micro-organisms by photoactivation. [23] [24] [25] [26] [27] However, the amount of ALA naturally produced in bacteria is insufficient to generate a bactericidal effect. Its exogenous administration elicits an increase in the intracellular concentration of PpIX and leads to inactivation of organisms via photodamage to their cellular structures. 28 Studies have shown that under blue light, the in vitro proliferation of S. aureus, was inhibited. 16, 17 Other studies also have described an association between the growth of S. pseudintermedius and photodynamic therapy (PDT). 29, 30 However, these studies used red rather than blue light, 29 or did not use photosensitizers. 30 Like other micro-organisms, S. pseudintermedius naturally produces ALA. 31 Based on previous studies, we hypothesized that blue light would inhibit the growth of S. pseudintermedius and that addition of exogenous ALA would enhance this effect.
Materials and methods

Bacterial isolates
Intact pustules of six dogs with superficial bacterial folliculitis were lanced with a 25-gauge needle and the contents were expressed onto a sterile swab. The samples were cultured aerobically on sheep blood agar (Asan Pharmaceutical; Hwasung, Korea) at 37°C for 18À24 h. Colonies suspected to be S. pseudintermedius based on their morphology were selected. The micro-organisms were identified by PCR using genomic DNA extracted from pure cultures, as described previously. 32 Amplification reactions were performed using a previously described protocol. 33 To amplify the 16S rRNA gene, the following two PCR primers were designed: forward primer (27F; 5 0 -AGAGTTTGATCCTGGCTCAG-3 0 ) and reverse primer (1492R;
. The National Center for Biotechnology Information (NCBI) basic local alignment search tool was then used to search the NCBI database for bacterial DNA nucleotide sequences and to identify the isolates as S. pseudintermedius.
Light
An LED array was designed for PDT. The array was composed of 144 super-luminescent diode units (U-Jin LED Co.; Goyang, Korea) that emitted blue light with a spectral width of 465-470 nm. Average power supplied to the LED system was 5.25 A and 3.5 V. The maximum area to be irradiated was 9 9 9 cm. The LED array was fixed onto the upper side of an acrylic box (width 10 cm, length 10 cm, height 7 cm). Distance between the top surface of the plates and the light-emitting end was 5 cm. 
Exposure of light to broth cultures
The extent of inhibition of S. pseudintermedius growth by blue light treatment was determined by measuring the optical density (OD) at a wavelength of 600 nm (OD 600 nm ). Absorbance was measured using a spectrophotometric plate reader (Epoch, BioTek; Winooski, VT, USA). Initially, an OD 600 nm of approximately 0.05 was achieved by diluting a single colony of each isolate with tryptic soy broth (Difco; Detroit, MI, USA). Subsequently, 200 lL of diluted bacterial culture was added into 96 well microtitre plates. Before measurement of OD 600 nm , samples in the plates were divided into three test groups (groups A, B and C, as per the TSA plates). The 96 well microtitre plates belonging to groups B and C were exposed to blue light (as per the TSA plates) and subsequently incubated at 37°C for 24 h. After incubation, bacterial growth was monitored by measuring the OD 600 nm at hourly intervals for 7 h. For each group, every dose was repeated in triplicate. Group D was excluded in this experiment because the colony counting test showed that ALA alone had no bactericidal effect.
Live/dead staining
The direct bactericidal effect of blue light, and blue light with ALA was visualized using epifluorescence staining with a LIVE/DEAD Bacterial Viability kit (L-7007, Invitrogen; Carlsbad, CA, USA) for two isolates chosen randomly from among the six bacteria. The green SYTO9 stain and red propidium iodine stain differ in their abilities to penetrate normal bacteria cells. Live bacteria with intact membranes fluoresce green, whereas dead bacteria with compromised membranes fluoresce red. Before staining, S. pseudintermedius was grown in tryptic soy broth until the late log phase. The bacterial culture was then divided into three test groups (namely groups A, B and C, as per the TSA plates). Group D was again excluded in this experiment. The solutions from groups B and C were exposed to blue light for 30 min. After incubating for 30 min under the respective conditions, specimens were stained according to the manufacturer's instructions and observed under an epifluorescent microscope. Live and dead bacteria can be viewed independently or simultaneously by fluorescence microscopy using a suitable optical filter. The excitation/emission maxima were approximately 450/490 nm for live and dead cells, and 510/560 nm for only dead cells. Fluorescence microscopic images were obtained using the Nikon Eclipse 80i fluorescent microscope (Nikon Instech Co., Ltd.; Tokyo, Japan) with oil immersion and 409 magnification.
The fluorescence intensity of images was quantified using the Image J software (NIH freeware, http://rsb.info.nih.gov/ij/download. html) as described previously. 34 The separated channels were analysed independently for live and dead fluorescent cells using the split function. For each treatment group, ten images were captured. The 
Statistical methods
All statistical analyses were conducted using SigmaPlot for Windows v12.0 (Systat Software Inc.; San Jose, CA, USA). Percentage survival between treatments was evaluated by repeated measures ANOVA. Dunnett's test was performed to compare treatment groups with the control group. A P-value < 0.05 was considered to be statistically significant. Quantification of fluorescence was subjected to the paired Student's t-test.
Results
Survival of the group treated with ALA alone was approximately 100%, regardless of the exposure time. Representative epifluorescent microscopic images are shown in Figure 3 . In the untreated control group, most cells were alive and it was difficult to detect dead cells (Figure 3a,b) . After treatment with blue light in the absence of ALA, the number of dead cells increased compared to that in the control group; however, the majority of cells remained viable (Figure 3c,d) . Epifluorescent images of S. pseudintermedius treated with blue light and ALA are shown in Figure 3e and f. Compared to the untreated group (Figure 3b) , a large proportion of dead cells was observed after treatment of blue light and ALA (Figure 3f ). . After irradiation, absorption at 600 nm was monitored at hourly intervals for 7 h. Blue light delayed S. pseudintermedius growth in a light dose-dependent manner. ALA enhanced the antibacterial effect of blue light (• Group A, no pretreatment; ○ Group B, pretreatment with light alone; ▼ Group C, pretreatment with light and ALA; *P < 0.05, **P < 0.01, significant difference both in groups B and C compared with control group). Figure 4 indicates the percentage viability of S. pseudintermedius following each treatment. The viability of cells exposed to blue light irradiation for 30 min was reduced to 84.23% (P < 0.01), whereas that of control group was 95.46%. When the bacteria were treated with blue light and ALA for 30 min, the viability dropped to 70.96% (P < 0.01).
Discussion
The results of this study revealed that blue LED irradiation, combined with ALA pretreatment, has a dosedependent antimicrobial effect on S. pseudintermedius. the nontreated group and addition of ALA as the photosensitizer further reduced colony counts. Testing confirmed that ALA alone had no bactericidal effects and its role was exclusively to enhance the photodynamic efficacy of blue light. The extent of S. pseudintermedius growth inhibition by blue light treatment also was tested in a broth microdilution model. As the light dose increased, replication of bacteria decreased and the extent of this inhibition was enhanced by adding the photosensitizer. However, a direct photodynamic effect could not be confirmed using these methods alone, because incubation was conducted over a 24 h period. Therefore, the LIVE/DEAD Bacterial Viability assay was used to confirm bacterial viability. Microscopic images of light-irradiated bacteria showed that the number of viable cells decreased compared to the number observed before light irradiation. Moreover, after adding ALA, the proportion of dead cells further increased. This demonstrated that blue LED induced photo-inactivation of S. pseudintermedius and that ALA was highly effective as a photosensitizer. Few studies have examined the effect of PDT on veterinary pathogens. One study investigated the effect of red light PDT against common bacteria causing canine skin infections. 29 In this study, red light (635 nm) was applied to wound-infecting bacteria including Streptococcus canis, Pseudomonas aeruginosa, Escherichia coli and S. pseudintermedius. To demonstrate the photodynamic effect of red light, bacterial survival was calculated by standard plate colony counting, which revealed a significant decrease in the bacterial survival rate following PDT for all organisms except for E. coli. The maximum count reduction for S. pseudintermedius (approximately 75%) was observed after 4 h of exposure with 0.1 mM ALA. At this point, the energy fluence was 216 J/cm². The present study has shown that exposure to blue light for 90 min with 10% ALA (55.2 J/cm²) reduced S. pseudintermedius by up to 97.86% (survival rate: 2.14%). Thus, compared to red light, blue light has a more powerful bactericidal effect against S. pseudintermedius.
A second study evaluated the bactericidal activity of blue light (465 nm) phototherapy on Staphylococcus spp. 30 In this study, blue light phototherapy reduced the colony counts of meticillin-resistant S. aureus, but not of meticillin-susceptible or meticillin-resistant S. pseudintermedius, which differs from our results It has been shown previously that the bactericidal effect of PDT for S. aureus is strain-dependent. 35 We therefore hypothesize that different strains of S. pseudintermedius also may exhibit a heterogeneous response to PDT, which could explain the differences in outcome between our study and the other study. 35 However, because strain typing was not performed on the isolates utilized for our studies, we cannot comment further on their potential heterogeneity.
In addition, we adjusted the photosensitizer to amplify the blue light PDT effect and demonstrated the efficiency of ALA. Our results suggest that the addition of exogenous ALA may enhance the production of endogenous porphyrins in S. pseudintermedius. These porphyrins acquired bactericidal ability from the blue light energy. The optimal spectrum width at which porphyrins absorb the maximal dose of light energy is approximately 400-420 nm. 26, 36 This optimal spectrum is not the same as that used in our study. However, the 465-470 nm spectrum width has a higher ability to penetrate the skin compared to 400-420 nm, and provides more efficient porphyrin photosensitization than the red light spectrum. 26 To use ALA as a topical application in patients, the commercial emulsion can be adjusted similar to that in human dermatology. 27 The concentration of ALA varies from 7.5% to 20%; with the 20% emulsion used most commonly in human medicine. 37 Topical ALA treatment does not induce systemic accumulation of ALA or porphyrins 46 and revealed only minor side effects, such as itching or erythema at a very low rate. 15, 38, 39 One limitation of this study is that we constructed the light-emitting device in-house, and thus the irradiation time was long in order to obtain sufficient light energy. If clinicians were to use commercial products for PDT, the duration of irradiation time would need to be substantially shortened. Previous studies, which have been conducted using commercial products, have demonstrated sufficient light energy to kill nearly all of the pathogens in a very short irradiation time. 11, 15, 16, 30, 40 For example, MR4 ACTIVet Pro (Multi Radiance Medical â ; Solon, OH, USA), a commercial product available for veterinary application, could produce 56.25 J/cm 2 of light energy in only 15 min of irradiation time, which is greater than the 55.2 J/cm 2 obtained in our 90 min irradiation period.
To the best of the authors' knowledge, this is the first in vitro study to evaluate the effect of blue light PDT with ALA as a photosensitizer on the canine pathogen S. pseudintermedius. This study has shown that blue LED has a high antibacterial effect and significantly inhibits the growth of S. pseudintermedius in a dose-dependent manner. Moreover, these effects are increased by exposure to ALA as a photosensitizer, which alone has no bactericidal effect. Additional studies are needed to validate the relationship between in vitro effects and clinical activity in canine bacterial pyoderma.
R esum e Contexte -Staphylococcus pseudintermedius est le principal pathog ene des infections bact eriennes cutan ees du chien. Une th erapie photodynamique (PDT) comprenant une lumi ere associ ee a un photosensibilisant est utilis ee chez l'homme pour traiter les infections bact eriennes cutan ees. etaient compar ees avec un test -t de Student. R esultats -La lumi ere bleue a inhib e la croissance de S. pseudintermedius; l'effet etait significativement augment e avec l'ajout de ALA en tant que photosensibilisant et avec des doses de lumi ere croissantes. La coloration vivante/morte a confirm e que la PDT a diminu e la viabilit e bact erienne et pr esentait un effet antibact erien. Conclusion et importance clinique -La lumi ere bleue a un effet antibact erien fort sur S. pseudintermedius d ependant de la dose de lumi ere. L'ALA seul n'a pas d'effet bact ericide mais son association a la lumiere bleue augmente l'effet de PDT compar e a la lumi ere bleue seule.
Resumen
Introducci on -Staphylococcus pseudintermedius es el principal agente pat ogeno que causa infecciones bacterianas en la piel en perros. La terapia fotodin amica (PDT) que implica la combinaci on de luz y un fotosensibilizador t opico se usa para tratar infecciones de la piel humana. Aunque los efectos antimicrobianos de la PDT se han demostrado mediante estudios in vivo e in vitro en humanos, sus efectos sobre los perros y sus pat ogenos no est an claros. Objetivos -El objetivo de este estudio fue demostrar la eficacia in vitro de la PDT en un espectro de 465-470 nm para eliminar S. pseudintermedius usando acido d-aminolevul ınico (ALA) como fotosensibilizador. M etodos -Seis aislados de S. pseudintermedius de la piel canina se expusieron a diodos emisores de luz (LEDs) azules a 465-470 nm, con o sin ALA. Las dosis de luz fueron 18,4, 36,8 y 55,2 J/cm 2 . Se midi o el n umero de unidades de formaci on de colonias y las densidades opticas de los cultivos de caldo y luego se compar o con la prueba de Dunnett. La viabilidad bacteriana se control o usando microscop ıa de fluorescencia y los valores de intensidad de fluorescencia se compararon con una prueba t de Student emparejada. Resultados -La luz azul inhibi o el crecimiento de S. pseudintermedius; el efecto aument o significativamente con la adici on de ALA como fotosensibilizador y con el aumento de la dosis de luz. La tinci on viva/ muerta confirm o que la PDT redujo la viabilidad bacteriana y ejerci o un efecto antibacteriano. Conclusi on e importancia cl ınica -la luz azul tiene un fuerte efecto antibacteriano sobre S. pseudintermedius de una manera dependiente de la dosis de luz. El ALA por s ı solo no mostr o acci on bactericida, pero su combinaci on con luz azul aument o el efecto de la PDT en comparaci on con la luz azul sola. 
